The type dimension of the Rose Hip Fruit Extracts market is principally divided into powder, liquid, capsule, and oil formats. Powder extracts dominate the segment due to their high solid‑content efficiency, ease of integration into functional foods, and lower logistics costs, accounting for roughly 40% of total revenue. Liquid extracts, valued for their rapid bioavailability and suitability for beverage fortification, contribute about 30%, driven by expanding nutraceutical beverage lines. Capsule forms, which encapsulate standardized doses, capture approximately 20% of the market, reflecting strong demand from the dietary‑supplement sector where dosage precision is critical. Oil extracts, though niche, represent the remaining 10%, primarily serving high‑end cosmetic applications that leverage the oil’s emollient properties. Each type aligns with distinct manufacturing processes and regulatory pathways, collectively shaping the overall market size by influencing cost structures, supply‑chain complexity, and end‑use suitability.